Search results
28 lut 2022 · IUD expulsions were analyzed in the full study cohort by postpartum timing interval at insertion and in the subcohort of women with breastfeeding status. We estimated incidence rates, cumulative incidence, and crude and adjusted hazard ratios (HRs) and their 95% CIs for risk of IUD expulsion.
15 cze 2024 · Three hundred twenty lactating women were randomized to either an IUD containing levonorgestrel (Mirena; n = 163) or the copper-containing IUD Cu T380A group (n = 157). Follow-up of infants for 1 year found no differences in growth and development or in duration of breastfeeding.
4 cze 2022 · Among individuals 52 weeks or less post partum, we found an increased risk of uterine perforation with breastfeeding at IUD insertion, but this added risk was smaller than previously reported and was most pronounced in the later post partum insertions.
The provision of a method requires expert clinical judgement and/or referral to a specialist contraceptive provider, since use of the method is not usually recommended unless other more appropriate methods are not available or not acceptable. (i) <15 cigarettes/day. (ii) ≥15 cigarettes/day.
The Mirena® system is used as a contraceptive method for women with excessively heavy periods. It can be inserted 6 weeks after delivery and is effective for 5 years. As with the depo injection in light of the response of some mothers to oral preparations of progesterone, it may be advisable to try one month of tablets before using the coil.
The post-partum subcohort of individuals with breastfeeding information had 673 uterine perforations (62% complete), with a 5-year cumulative incidence of 1·37% (95% CI 1·24–1·52) and an increased risk with breastfeeding (aHR 1·37, 95% CI 1·12–1·66).
The manufacturer of Mirena® 20 micrograms/24 hours intrauterine delivery system states that in case of an accidental pregnancy with the device in situ, the device should be removed as soon as possible due to an increased risk of abortion and preterm labour.
